Index by author
September 01, 1994; Volume 22,Issue 5
A
Amann, M T
- You have accessThe in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S GarveyDrug Metabolism and Disposition September 1994, 22 (5) 788-798;
B
Bai, S A
- You have accessEffects of diltiazem on the disposition and metabolism of the enantiomers of propranolol in the dog during multiple oral dosing.S M Lankford, C Maskasame and S A BaiDrug Metabolism and Disposition September 1994, 22 (5) 776-787;
Baker, G B
- You have accessMetabolism of methoxyphenamine in vitro by a CYP2D6 microsomal preparation.R T Coutts, O O Bolaji, P Su and G B BakerDrug Metabolism and Disposition September 1994, 22 (5) 756-760;
Bolaji, O O
- You have accessMetabolism of methoxyphenamine in vitro by a CYP2D6 microsomal preparation.R T Coutts, O O Bolaji, P Su and G B BakerDrug Metabolism and Disposition September 1994, 22 (5) 756-760;
Burcham, D L
- You have accessPharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs.M F Grubb, Y N Wong, D L Burcham, P L Saxton, C Y Quon and S M HuangDrug Metabolism and Disposition September 1994, 22 (5) 709-712;
Buters, J T
- You have accesscDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus.J T Buters, K R Korzekwa, K L Kunze, Y Omata, J P Hardwick and F J GonzalezDrug Metabolism and Disposition September 1994, 22 (5) 688-692;
C
Cepa, S P
- You have accessThe in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S GarveyDrug Metabolism and Disposition September 1994, 22 (5) 788-798;
Chang, T K
- You have access1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) modulates rat liver microsomal cyclophosphamide and ifosphamide activation by suppressing cytochrome P450 2C11 messenger RNA levels.T K Chang, H Chen and D J WaxmanDrug Metabolism and Disposition September 1994, 22 (5) 673-679;
Charkowski, D M
- You have accessStudies on the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomes.T R Tephly, B Coffman, P Styczynski, G Rios, D M Charkowski, M Vanrollins, R D McQuade and C E TedfordDrug Metabolism and Disposition September 1994, 22 (5) 713-718;
Charman, W N
- You have accessPharmacokinetics of dapsone and amino acid prodrugs of dapsone.N L Pochopin, W N Charman and V J StellaDrug Metabolism and Disposition September 1994, 22 (5) 770-775;
Chen, H
- You have access1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) modulates rat liver microsomal cyclophosphamide and ifosphamide activation by suppressing cytochrome P450 2C11 messenger RNA levels.T K Chang, H Chen and D J WaxmanDrug Metabolism and Disposition September 1994, 22 (5) 673-679;
Chen, I W
- You have accessPhysiological disposition of L-663,581, a partial agonist of the benzodiazepine receptor, in laboratory animals.I W Chen and J H LinDrug Metabolism and Disposition September 1994, 22 (5) 693-699;
Chiu, S H
- You have accessFK 506 metabolism in human liver microsomes: investigation of the involvement of cytochrome P450 isozymes other than CYP3A4.B V Karanam, S H Vincent, D J Newton, R W Wang and S H ChiuDrug Metabolism and Disposition September 1994, 22 (5) 811-814;
Coffman, B
- You have accessStudies on the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomes.T R Tephly, B Coffman, P Styczynski, G Rios, D M Charkowski, M Vanrollins, R D McQuade and C E TedfordDrug Metabolism and Disposition September 1994, 22 (5) 713-718;
Coutts, R T
- You have accessMetabolism of methoxyphenamine in vitro by a CYP2D6 microsomal preparation.R T Coutts, O O Bolaji, P Su and G B BakerDrug Metabolism and Disposition September 1994, 22 (5) 756-760;
D
Dekant, W
- You have accessRole of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.U Köster, P Speerschneider, R Kerssebaum, H Wittmann and W DekantDrug Metabolism and Disposition September 1994, 22 (5) 667-672;
Dow, J
- You have accessNovel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.J Dow, F Piriou, E Wolf, B D Dulery and K D HaegeleDrug Metabolism and Disposition September 1994, 22 (5) 738-749;
Dulery, B D
- You have accessNovel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.J Dow, F Piriou, E Wolf, B D Dulery and K D HaegeleDrug Metabolism and Disposition September 1994, 22 (5) 738-749;
F
Ferrero, J L
- You have accessThe in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S GarveyDrug Metabolism and Disposition September 1994, 22 (5) 788-798;
Fujimaki, M
- You have accessOxidation of R(+)- and S(-)-carvedilol by rat liver microsomes. Evidence for stereoselective oxidation and characterization of the cytochrome P450 isozymes involved.M FujimakiDrug Metabolism and Disposition September 1994, 22 (5) 700-708;
G
Gal, J
- You have accessStereoselective hydroxylation of tacrine in rats and humans.W D Hooper, W F Pool, T F Woolf and J GalDrug Metabolism and Disposition September 1994, 22 (5) 719-724;
Garvey, D S
- You have accessThe in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S GarveyDrug Metabolism and Disposition September 1994, 22 (5) 788-798;
Gescher, A
- You have accessInhibition of p-nitrophenol hydroxylase in rat liver microsomes by small aromatic and heterocyclic molecules.M B Hargreaves, B C Jones, D A Smith and A GescherDrug Metabolism and Disposition September 1994, 22 (5) 806-810;
Gonzalez, F J
- You have accesscDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus.J T Buters, K R Korzekwa, K L Kunze, Y Omata, J P Hardwick and F J GonzalezDrug Metabolism and Disposition September 1994, 22 (5) 688-692;
Goto, M
- You have accessRole of Kupffer cells in storage and metabolism of benzo(a)pyrene in the liver.Z Zhong, M Goto, T Hijioka, H Oide, F C Kauffman and R G ThurmanDrug Metabolism and Disposition September 1994, 22 (5) 680-687;
Green, M D
- You have accessStable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates.M D Green, E M Oturu and T R TephlyDrug Metabolism and Disposition September 1994, 22 (5) 799-805;
Gregus, Z
- You have accessSulfation of acetaminophen and acetaminophen-induced alterations in sulfate and 3'-phosphoadenosine 5'-phosphosulfate homeostasis in rats with deficient dietary intake of sulfur.Z Gregus, H J Kim, C Madhu, Y Liu, P Rozman and C D KlaassenDrug Metabolism and Disposition September 1994, 22 (5) 725-730;
Grubb, M F
- You have accessPharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs.M F Grubb, Y N Wong, D L Burcham, P L Saxton, C Y Quon and S M HuangDrug Metabolism and Disposition September 1994, 22 (5) 709-712;
Guenthner, T M
- You have accessDetoxication of the 2',3'-epoxide metabolites of allylbenzene and estragole. Conjugation with glutathione.G Luo and T M GuenthnerDrug Metabolism and Disposition September 1994, 22 (5) 731-737;
H
Haegele, K D
- You have accessNovel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.J Dow, F Piriou, E Wolf, B D Dulery and K D HaegeleDrug Metabolism and Disposition September 1994, 22 (5) 738-749;
Hardwick, J P
- You have accesscDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus.J T Buters, K R Korzekwa, K L Kunze, Y Omata, J P Hardwick and F J GonzalezDrug Metabolism and Disposition September 1994, 22 (5) 688-692;
Hargreaves, M B
- You have accessInhibition of p-nitrophenol hydroxylase in rat liver microsomes by small aromatic and heterocyclic molecules.M B Hargreaves, B C Jones, D A Smith and A GescherDrug Metabolism and Disposition September 1994, 22 (5) 806-810;
Hashizaki, M
- You have accessCarbonyl reduction of 6-tert-butyl-2,3-epoxy-1,4-benzoquinone, a metabolite of 3-tert-butyl-4-hydroxyanisole, by rat liver microsomes and cytosol.K Tajima, M Hashizaki, K Yamamoto and T MizutaniDrug Metabolism and Disposition September 1994, 22 (5) 815-818;
Hijioka, T
- You have accessRole of Kupffer cells in storage and metabolism of benzo(a)pyrene in the liver.Z Zhong, M Goto, T Hijioka, H Oide, F C Kauffman and R G ThurmanDrug Metabolism and Disposition September 1994, 22 (5) 680-687;
Hirobe, M
- You have accessInter-individual differences of 4-[4-(4-methylphenyl)-phenylmethoxy-1-piperidinyl]butyric acid disposition in rats: possible involvement of genetic polymorphism.E Takahara, O Nagata, H Kato, S Ohta and M HirobeDrug Metabolism and Disposition September 1994, 22 (5) 761-769;
Hooper, W D
- You have accessStereoselective hydroxylation of tacrine in rats and humans.W D Hooper, W F Pool, T F Woolf and J GalDrug Metabolism and Disposition September 1994, 22 (5) 719-724;
Huang, S M
- You have accessPharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs.M F Grubb, Y N Wong, D L Burcham, P L Saxton, C Y Quon and S M HuangDrug Metabolism and Disposition September 1994, 22 (5) 709-712;
J
Jones, B C
- You have accessInhibition of p-nitrophenol hydroxylase in rat liver microsomes by small aromatic and heterocyclic molecules.M B Hargreaves, B C Jones, D A Smith and A GescherDrug Metabolism and Disposition September 1994, 22 (5) 806-810;
K
Karanam, B V
- You have accessFK 506 metabolism in human liver microsomes: investigation of the involvement of cytochrome P450 isozymes other than CYP3A4.B V Karanam, S H Vincent, D J Newton, R W Wang and S H ChiuDrug Metabolism and Disposition September 1994, 22 (5) 811-814;
Kato, H
- You have accessInter-individual differences of 4-[4-(4-methylphenyl)-phenylmethoxy-1-piperidinyl]butyric acid disposition in rats: possible involvement of genetic polymorphism.E Takahara, O Nagata, H Kato, S Ohta and M HirobeDrug Metabolism and Disposition September 1994, 22 (5) 761-769;
Kauffman, F C
- You have accessRole of Kupffer cells in storage and metabolism of benzo(a)pyrene in the liver.Z Zhong, M Goto, T Hijioka, H Oide, F C Kauffman and R G ThurmanDrug Metabolism and Disposition September 1994, 22 (5) 680-687;
Kawazoe, S
- You have accessFormation of toxic metabolites from thiabendazole and other thiazoles in mice. Identification of thioamides as ring cleavage products.T Mizutani, K Yoshida and S KawazoeDrug Metabolism and Disposition September 1994, 22 (5) 750-755;
Kerssebaum, R
- You have accessRole of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.U Köster, P Speerschneider, R Kerssebaum, H Wittmann and W DekantDrug Metabolism and Disposition September 1994, 22 (5) 667-672;
Kim, H J
- You have accessSulfation of acetaminophen and acetaminophen-induced alterations in sulfate and 3'-phosphoadenosine 5'-phosphosulfate homeostasis in rats with deficient dietary intake of sulfur.Z Gregus, H J Kim, C Madhu, Y Liu, P Rozman and C D KlaassenDrug Metabolism and Disposition September 1994, 22 (5) 725-730;
Klaassen, C D
- You have accessSulfation of acetaminophen and acetaminophen-induced alterations in sulfate and 3'-phosphoadenosine 5'-phosphosulfate homeostasis in rats with deficient dietary intake of sulfur.Z Gregus, H J Kim, C Madhu, Y Liu, P Rozman and C D KlaassenDrug Metabolism and Disposition September 1994, 22 (5) 725-730;
Korzekwa, K R
- You have accesscDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus.J T Buters, K R Korzekwa, K L Kunze, Y Omata, J P Hardwick and F J GonzalezDrug Metabolism and Disposition September 1994, 22 (5) 688-692;
Köster, U
- You have accessRole of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.U Köster, P Speerschneider, R Kerssebaum, H Wittmann and W DekantDrug Metabolism and Disposition September 1994, 22 (5) 667-672;
Kunze, K L
- You have accesscDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus.J T Buters, K R Korzekwa, K L Kunze, Y Omata, J P Hardwick and F J GonzalezDrug Metabolism and Disposition September 1994, 22 (5) 688-692;
L
Lankford, S M
- You have accessEffects of diltiazem on the disposition and metabolism of the enantiomers of propranolol in the dog during multiple oral dosing.S M Lankford, C Maskasame and S A BaiDrug Metabolism and Disposition September 1994, 22 (5) 776-787;
Lin, J H
- You have accessPhysiological disposition of L-663,581, a partial agonist of the benzodiazepine receptor, in laboratory animals.I W Chen and J H LinDrug Metabolism and Disposition September 1994, 22 (5) 693-699;
Liu, Y
- You have accessSulfation of acetaminophen and acetaminophen-induced alterations in sulfate and 3'-phosphoadenosine 5'-phosphosulfate homeostasis in rats with deficient dietary intake of sulfur.Z Gregus, H J Kim, C Madhu, Y Liu, P Rozman and C D KlaassenDrug Metabolism and Disposition September 1994, 22 (5) 725-730;
Luo, G
- You have accessDetoxication of the 2',3'-epoxide metabolites of allylbenzene and estragole. Conjugation with glutathione.G Luo and T M GuenthnerDrug Metabolism and Disposition September 1994, 22 (5) 731-737;
M
Machinist, J M
- You have accessThe in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S GarveyDrug Metabolism and Disposition September 1994, 22 (5) 788-798;
Madhu, C
- You have accessSulfation of acetaminophen and acetaminophen-induced alterations in sulfate and 3'-phosphoadenosine 5'-phosphosulfate homeostasis in rats with deficient dietary intake of sulfur.Z Gregus, H J Kim, C Madhu, Y Liu, P Rozman and C D KlaassenDrug Metabolism and Disposition September 1994, 22 (5) 725-730;
Maskasame, C
- You have accessEffects of diltiazem on the disposition and metabolism of the enantiomers of propranolol in the dog during multiple oral dosing.S M Lankford, C Maskasame and S A BaiDrug Metabolism and Disposition September 1994, 22 (5) 776-787;
McQuade, R D
- You have accessStudies on the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomes.T R Tephly, B Coffman, P Styczynski, G Rios, D M Charkowski, M Vanrollins, R D McQuade and C E TedfordDrug Metabolism and Disposition September 1994, 22 (5) 713-718;
Mizutani, T
- You have accessFormation of toxic metabolites from thiabendazole and other thiazoles in mice. Identification of thioamides as ring cleavage products.T Mizutani, K Yoshida and S KawazoeDrug Metabolism and Disposition September 1994, 22 (5) 750-755;
- You have accessCarbonyl reduction of 6-tert-butyl-2,3-epoxy-1,4-benzoquinone, a metabolite of 3-tert-butyl-4-hydroxyanisole, by rat liver microsomes and cytosol.K Tajima, M Hashizaki, K Yamamoto and T MizutaniDrug Metabolism and Disposition September 1994, 22 (5) 815-818;
N
Nagata, O
- You have accessInter-individual differences of 4-[4-(4-methylphenyl)-phenylmethoxy-1-piperidinyl]butyric acid disposition in rats: possible involvement of genetic polymorphism.E Takahara, O Nagata, H Kato, S Ohta and M HirobeDrug Metabolism and Disposition September 1994, 22 (5) 761-769;
Newton, D J
- You have accessFK 506 metabolism in human liver microsomes: investigation of the involvement of cytochrome P450 isozymes other than CYP3A4.B V Karanam, S H Vincent, D J Newton, R W Wang and S H ChiuDrug Metabolism and Disposition September 1994, 22 (5) 811-814;
O
Ohta, S
- You have accessInter-individual differences of 4-[4-(4-methylphenyl)-phenylmethoxy-1-piperidinyl]butyric acid disposition in rats: possible involvement of genetic polymorphism.E Takahara, O Nagata, H Kato, S Ohta and M HirobeDrug Metabolism and Disposition September 1994, 22 (5) 761-769;
Oide, H
- You have accessRole of Kupffer cells in storage and metabolism of benzo(a)pyrene in the liver.Z Zhong, M Goto, T Hijioka, H Oide, F C Kauffman and R G ThurmanDrug Metabolism and Disposition September 1994, 22 (5) 680-687;
Omata, Y
- You have accesscDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus.J T Buters, K R Korzekwa, K L Kunze, Y Omata, J P Hardwick and F J GonzalezDrug Metabolism and Disposition September 1994, 22 (5) 688-692;
Oturu, E M
- You have accessStable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates.M D Green, E M Oturu and T R TephlyDrug Metabolism and Disposition September 1994, 22 (5) 799-805;
P
Piriou, F
- You have accessNovel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.J Dow, F Piriou, E Wolf, B D Dulery and K D HaegeleDrug Metabolism and Disposition September 1994, 22 (5) 738-749;
Pochopin, N L
- You have accessPharmacokinetics of dapsone and amino acid prodrugs of dapsone.N L Pochopin, W N Charman and V J StellaDrug Metabolism and Disposition September 1994, 22 (5) 770-775;
Pool, W F
- You have accessStereoselective hydroxylation of tacrine in rats and humans.W D Hooper, W F Pool, T F Woolf and J GalDrug Metabolism and Disposition September 1994, 22 (5) 719-724;
Q
Quon, C Y
- You have accessPharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs.M F Grubb, Y N Wong, D L Burcham, P L Saxton, C Y Quon and S M HuangDrug Metabolism and Disposition September 1994, 22 (5) 709-712;
R
Rios, G
- You have accessStudies on the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomes.T R Tephly, B Coffman, P Styczynski, G Rios, D M Charkowski, M Vanrollins, R D McQuade and C E TedfordDrug Metabolism and Disposition September 1994, 22 (5) 713-718;
Rodrigues, A D
- You have accessThe in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S GarveyDrug Metabolism and Disposition September 1994, 22 (5) 788-798;
Rotert, G A
- You have accessThe in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S GarveyDrug Metabolism and Disposition September 1994, 22 (5) 788-798;
Rozman, P
- You have accessSulfation of acetaminophen and acetaminophen-induced alterations in sulfate and 3'-phosphoadenosine 5'-phosphosulfate homeostasis in rats with deficient dietary intake of sulfur.Z Gregus, H J Kim, C Madhu, Y Liu, P Rozman and C D KlaassenDrug Metabolism and Disposition September 1994, 22 (5) 725-730;
S
Saxton, P L
- You have accessPharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs.M F Grubb, Y N Wong, D L Burcham, P L Saxton, C Y Quon and S M HuangDrug Metabolism and Disposition September 1994, 22 (5) 709-712;
Smith, D A
- You have accessInhibition of p-nitrophenol hydroxylase in rat liver microsomes by small aromatic and heterocyclic molecules.M B Hargreaves, B C Jones, D A Smith and A GescherDrug Metabolism and Disposition September 1994, 22 (5) 806-810;
Speerschneider, P
- You have accessRole of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.U Köster, P Speerschneider, R Kerssebaum, H Wittmann and W DekantDrug Metabolism and Disposition September 1994, 22 (5) 667-672;
Stella, V J
- You have accessPharmacokinetics of dapsone and amino acid prodrugs of dapsone.N L Pochopin, W N Charman and V J StellaDrug Metabolism and Disposition September 1994, 22 (5) 770-775;
Styczynski, P
- You have accessStudies on the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomes.T R Tephly, B Coffman, P Styczynski, G Rios, D M Charkowski, M Vanrollins, R D McQuade and C E TedfordDrug Metabolism and Disposition September 1994, 22 (5) 713-718;
Su, P
- You have accessMetabolism of methoxyphenamine in vitro by a CYP2D6 microsomal preparation.R T Coutts, O O Bolaji, P Su and G B BakerDrug Metabolism and Disposition September 1994, 22 (5) 756-760;
Sullivan, J P
- You have accessThe in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S GarveyDrug Metabolism and Disposition September 1994, 22 (5) 788-798;
Surber, B W
- You have accessThe in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S GarveyDrug Metabolism and Disposition September 1994, 22 (5) 788-798;
T
Tajima, K
- You have accessCarbonyl reduction of 6-tert-butyl-2,3-epoxy-1,4-benzoquinone, a metabolite of 3-tert-butyl-4-hydroxyanisole, by rat liver microsomes and cytosol.K Tajima, M Hashizaki, K Yamamoto and T MizutaniDrug Metabolism and Disposition September 1994, 22 (5) 815-818;
Takahara, E
- You have accessInter-individual differences of 4-[4-(4-methylphenyl)-phenylmethoxy-1-piperidinyl]butyric acid disposition in rats: possible involvement of genetic polymorphism.E Takahara, O Nagata, H Kato, S Ohta and M HirobeDrug Metabolism and Disposition September 1994, 22 (5) 761-769;
Tedford, C E
- You have accessStudies on the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomes.T R Tephly, B Coffman, P Styczynski, G Rios, D M Charkowski, M Vanrollins, R D McQuade and C E TedfordDrug Metabolism and Disposition September 1994, 22 (5) 713-718;
Tephly, T R
- You have accessStudies on the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomes.T R Tephly, B Coffman, P Styczynski, G Rios, D M Charkowski, M Vanrollins, R D McQuade and C E TedfordDrug Metabolism and Disposition September 1994, 22 (5) 713-718;
- You have accessStable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates.M D Green, E M Oturu and T R TephlyDrug Metabolism and Disposition September 1994, 22 (5) 799-805;
Thurman, R G
- You have accessRole of Kupffer cells in storage and metabolism of benzo(a)pyrene in the liver.Z Zhong, M Goto, T Hijioka, H Oide, F C Kauffman and R G ThurmanDrug Metabolism and Disposition September 1994, 22 (5) 680-687;
Tich, N R
- You have accessThe in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.A D Rodrigues, J L Ferrero, M T Amann, G A Rotert, S P Cepa, B W Surber, J M Machinist, N R Tich, J P Sullivan and D S GarveyDrug Metabolism and Disposition September 1994, 22 (5) 788-798;
V
Vanrollins, M
- You have accessStudies on the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomes.T R Tephly, B Coffman, P Styczynski, G Rios, D M Charkowski, M Vanrollins, R D McQuade and C E TedfordDrug Metabolism and Disposition September 1994, 22 (5) 713-718;
Vincent, S H
- You have accessFK 506 metabolism in human liver microsomes: investigation of the involvement of cytochrome P450 isozymes other than CYP3A4.B V Karanam, S H Vincent, D J Newton, R W Wang and S H ChiuDrug Metabolism and Disposition September 1994, 22 (5) 811-814;
W
Wang, R W
- You have accessFK 506 metabolism in human liver microsomes: investigation of the involvement of cytochrome P450 isozymes other than CYP3A4.B V Karanam, S H Vincent, D J Newton, R W Wang and S H ChiuDrug Metabolism and Disposition September 1994, 22 (5) 811-814;
Waxman, D J
- You have access1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) modulates rat liver microsomal cyclophosphamide and ifosphamide activation by suppressing cytochrome P450 2C11 messenger RNA levels.T K Chang, H Chen and D J WaxmanDrug Metabolism and Disposition September 1994, 22 (5) 673-679;
Wittmann, H
- You have accessRole of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.U Köster, P Speerschneider, R Kerssebaum, H Wittmann and W DekantDrug Metabolism and Disposition September 1994, 22 (5) 667-672;
Wolf, E
- You have accessNovel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.J Dow, F Piriou, E Wolf, B D Dulery and K D HaegeleDrug Metabolism and Disposition September 1994, 22 (5) 738-749;
Wong, Y N
- You have accessPharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs.M F Grubb, Y N Wong, D L Burcham, P L Saxton, C Y Quon and S M HuangDrug Metabolism and Disposition September 1994, 22 (5) 709-712;
Woolf, T F
- You have accessStereoselective hydroxylation of tacrine in rats and humans.W D Hooper, W F Pool, T F Woolf and J GalDrug Metabolism and Disposition September 1994, 22 (5) 719-724;
Y
Yamamoto, K
- You have accessCarbonyl reduction of 6-tert-butyl-2,3-epoxy-1,4-benzoquinone, a metabolite of 3-tert-butyl-4-hydroxyanisole, by rat liver microsomes and cytosol.K Tajima, M Hashizaki, K Yamamoto and T MizutaniDrug Metabolism and Disposition September 1994, 22 (5) 815-818;
Yoshida, K
- You have accessFormation of toxic metabolites from thiabendazole and other thiazoles in mice. Identification of thioamides as ring cleavage products.T Mizutani, K Yoshida and S KawazoeDrug Metabolism and Disposition September 1994, 22 (5) 750-755;
Z
Zhong, Z
- You have accessRole of Kupffer cells in storage and metabolism of benzo(a)pyrene in the liver.Z Zhong, M Goto, T Hijioka, H Oide, F C Kauffman and R G ThurmanDrug Metabolism and Disposition September 1994, 22 (5) 680-687;
In this issue

Advertisement